Greg Bolan

Avondale Partners maintains its Market Perform rating and $14 price target on Quality Systems, Inc. (NASDAQ: QSII), saying the company faces many challenges despite commencing turnaround efforts. "We remain neutral on QSII's ability to elevate HealthFusion above the price war at the bottom of the...

Avondale Partners downgraded PAREXEL International Corporation (NASDAQ: PRXL) to Underperform on Monday. The experts also reduced their estimates and price target from $60 to $49. In a report issued Monday, Avondale analysts Greg Bolan and Steven Couche downgraded PAREXEL to Underperform...